Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.
- DOI
- 10.1136/gutjnl-2026-338390
- Published
- 2026 Sep 11
- Container
- Gut
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/gutjnl-2026-338390,
title = {Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.},
author = {Soriano I and Sherwood K and Ward JC and Fernandez-Tajes J and Amanullah A and Thorn S and Gul G and Wilson JF and Isaksson A and Glimelius B and Sjöblom T and Palles C and Tomlinson I},
year = {2026},
journal = {Gut},
doi = {10.1136/gutjnl-2026-338390},
url = {https://doi.org/10.1136/gutjnl-2026-338390}
}RIS
TY - JOUR TI - Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk. AU - Soriano I AU - Sherwood K AU - Ward JC AU - Fernandez-Tajes J AU - Amanullah A AU - Thorn S AU - Gul G AU - Wilson JF AU - Isaksson A AU - Glimelius B AU - Sjöblom T AU - Palles C AU - Tomlinson I PY - 2026 JO - Gut DO - 10.1136/gutjnl-2026-338390 UR - https://doi.org/10.1136/gutjnl-2026-338390 ER -
APA
I, S., K, S., JC, W., J, F., A, A., S, T., G, G., JF, W., A, I., B, G., T, S., C, P., & I, T. (2026). Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.. Gut. https://doi.org/10.1136/gutjnl-2026-338390
Source records
- pubmed · retrieved 2026-09-26T04:28:48.860Z